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Abstract 
Rosa canina (RC, the Dog Rose) is used in European folk medicine for the treatment of 
various human ailments. The crude methanol extract of this botanical was tested against 
multidrug-resistant (MDR) bacterial strains including methicillin-resistant Staphylococcus 
aureus SA1199B, EMRSA-16 and XU212 harbouring NorA, PBP2a and TetK resistance 
mechanisms, respectively, as well as S. aureus ATCC25923, a standard antimicrobial–
susceptible laboratory strain. Inhibition of the conjugal transfer of plasmids PKM101 and 
TP114 by the RC extract was also evaluated. The RC extract demonstrated a mild to poor 
antibacterial activity against the panel of bacteria having MIC values ranging from 256 to 
>512 mg/L, but strongly potentiated tetracycline activity (64-fold) against XU212, a 
tetracycline-effluxing and resistant strain. Furthermore, the extract showed moderate capacity 
to inhibit the conjugal transfer of TP114 and PKM101;  transfer frequencies were between 
40% and 45%. Cytotoxicity analysis of the RC extract against HepG2 cells line showed the 
IC50 >500µg/mL and thus was considered non-toxic toward human cells. Phytochemical 
characterisation of the extracts was performed by the assessment of total phenolic content 
(RC: 60.86 mg TAE/g) and by HPLC fingerprint determination. The results from this study 
provide new mechanistic evidence justifying, at least in part, the traditional use of this 
extract. However, the inhibition of bacterial plasmid conjugation opens the possibility of 
combination therapies to overcome antibiotic-resistance. 
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1. Introduction 
The rapid spread of multidrug-resistant (MDR) bacteria has posed a serious global health 
threat over the last few decades and continues to constitute a major problem in the treatment 
of hospital- and community-acquired infections [1]. As a consequence, treatment of 
infections caused by MDR bacteria strains is becoming increasingly difficult to manage with 
existing antibiotics. This is in part due to the ability of bacteria to evolve mechanisms that 
thwart antimicrobial action [2]. Diverse strains of Staphylococcus aureus such as SA-1199B 
(NorA), XU-212 (TetK and PBP2a), RN-4220 (MsrA), EMRSA-15 and -16 (PBP2a) are 
prominent for their high level of resistance to antibiotics via efflux mechanisms and altered 
target site [3, 4]. Recent studies have suggested that the horizontal transmission of genes 
conferring antibiotic resistance may be the dominant force behind the growing problem of 
antibiotic resistance [5]. For instance, dissemination of extended-spectrum beta-lactamase 
(ESBL) genes, conferring resistance to third-generation cephalosporins and other β-lactams, 
via plasmid transmission has been reported amongst certain bacteria such as Escherichia coli, 
Klebsiella pneumoniae and Acinetobacter spp. [6]. These plasmid-mediated multidrug 
resistance phenotypes are well known for affecting the treatment of infectious human 
diseases [7]. Unfortunately, synthetic plasmid-curing agents such as acridine orange, 
ethidium bromide and sodium dodecylsulfate are unsuitable for therapeutic application owing 
to their toxic nature. There is therefore a need to develop new antibiotics with alternative 
mechanisms to overcome bacterial resistance, particularly as resistance modifying efflux 
inhibitors or plasmid curing compounds [8, 9]. In this context, plant-derived products have 
been proposed as a new source of drug leads to combat bacterial resistance mechanisms [10] 
through the reversal of MDR phenotypes facilitating the re-establishment of use of existing 
antibiotics. 
Rosa canina L (Rosaceae; RC) known as Rose Hip or Dog Rose is mostly used traditionally 
as a dietary supplement and a herbal remedy for the prevention and treatment of diverse 
human diseases such as diabetes, kidney disorders, inflammation, common cold, ulcer and 
cancer, but only a few of these have any in vitro scientific data to support these indications 
[11]. The strong anti-microbial potential of Rosa canina against many micro-organisms has 
been documented [12]. The folkloric medicinal provides a significant source of ascorbic acid, 
tocopherol, tannins, pectin, minerals, fatty acids, carotenoids and phenolic compounds [13, 
14]. It has previously been reported that tellimagrandin I isolated from RC reduced the MIC 
of oxacillin and tetracycline against four MRSA strains [15]. Presently, there is no scientific 
data on the antibacterial properties of RC against strains with characterised efflux-mediated 
mechanisms of resistance or the capacity to inhibit plasmid transfer. This study therefore 
aimed to investigate the antibacterial, plasmid conjugation inhibition and antibiotic 
modulation potential of the methanol extract of Rosa canina fruit against selected MDR S. 
aureus strains. In addition, their differential cytotoxicity against mammal cells expressing 
efflux pumps was also determined using the Sulphorhodamine B (SRB) assay with human 
liver carcinoma cells (HepG2). 
2. Results and discussion 
2.1  Total phenolic content (TPC) 
Due to the lack of an appropriate standard, the TPC of the RC extract was expressed as tannic 
acid equivalents (TAE). The TPC value was found to be 60.86±0.04 mgTAE/g for RC, 
extrapolated from the standard tannic acid curve: Y= 0.1216x; R2= 0.93651. The data 
recorded for RC fruits was contrary to that of Montazeri et al [16] who reported 424.6±1.8 
mg/gallic acid equivalent (GAE)/g but corroborated with the findings (59.69±0.89 mg GAE/g 
dry matter) of IIbay et al. [17]. The observed inconsistency could be attributed to different 
climatic conditions, the standard equivalent used, solvent system and/or processing methods. 
Moreover, Folin Ciocalteu reagent (FCR) has been used to measure other compounds and 
hence may not give a concise amount of the phenolic compounds present. However, a 
HPLC/DAD chromatogram with detection at 360 nm revealed the presence of seven major 
peaks of phenolic compounds for the RC extract (data not shown) between a retention time of 
2 and 38 min.  
2.2  Antibacterial activity of RC extract  
The methanol extract showed a mild to poor antibacterial activity with minimum inhibitory 
concentration (MIC) values ranging between 256 and >512 mg/L whereas the standard 
antibiotics used as controls ranged from ≤0.03 to 0.5 mg/L as summarized in Table 1. 
According to Rios and Recio [18] extracts can be classified as significant (MIC < 100 mg/L), 
moderate (100 < MIC = 512 mg/L) or weak (MIC > 512 mg/L) depending upon their 
respective activities against the corresponding pathogens. Utilising this scheme, the RC 
extract demonstrated  moderate antibacterial activity against EMRSA-15 and EMRSA-16 [3, 
4], the major epidemic methicillin-resistant S. aureus strains occurring in UK hospital, as 
well as Proteus vulgaris 10330 and Pseudomonas aeruginosa 10662 with MIC values 
ranging between 256 and 512 mg/L, but was less active towards other MDR organisms (MIC 
>512 mg/L). The poor antibacterial activity of RC fruit is consistent with the report of 
Yilmaz and Ercisli [19] against certain bacteria. Although the MIC values obtained from 
extracts against the test organisms were much higher compared to the antimicrobial agents 
this is likely to be due to the complex mixture of the phytochemicals in the sample.  
2.3 Antibiotic resistance modifying activity  
The bacterial resistance-modifying activity of the RC extract in the presence of either 
norfloxacin or tetracycline against four bacterial strains (SA1199B, XU212, ATCC 25923 
and EMRSA-16) is depicted in Table 2. The combination of RC extract with norfloxacin had 
no effect on the activities towards EMRSA-16 and ATCC 25923. Interestingly, an increase in 
the MIC of norfloxacin was recorded against SA1199B, suggesting antagonism. Moreover, 
when tested against the tetracycline-resistant strain (XU212) expressing the TetK efflux 
transporter, a sixty-four-fold reduction in the MIC was noted at a sub-inhibitory 
concentration (SIC). When reserpine, a known efflux inhibitor, was combined with 
norfloxacin or tetracycline a four-fold potentiation was observed towards EMRSA-16, ATCC 
25923 and XU212 while eight fold reductions in the MIC of norfloxacin was displayed 
against SA1199B. The development of efflux pump inhibitors has been proposed to be used 
in conjunction with existing antibiotics to improve therapeutic efficacy and suppress the 
emergence of resistant variants that may arise during treatment [20]. Although, the plant 
extract showed promising resistance modifying properties against XU212 and appeared to 
overcome the efflux mechanisms present, the isolation of their active principles could provide 
useful drug leads to reverse antibiotic resistance mechanisms in clinically-relevant pathogens. 
2.4 Plasmid conjugal inhibition activity  
The search for inhibitors of plasmid-mediated resistance is currently gaining new ground, 
with only a small number of synthetic compounds identified [21], which are unsuitable for 
clinical application due to their neurotoxicity. Consequently, recent studies have concentrated 
on natural products in order to identify natural inhibitors of bacterial conjugation [22]. Here, 
the RC extract was evaluated to assess its capacity to reduce the transfer frequency of the 
plasmids TP114 and PKM10. TP114 is a self-transmissible plasmid belonging to Incl2 
compatibility group isolated from E. coli [23] and encodes a kanamycin resistance 
determinant. PKM 101 belongs to the IncN compatibility group, is a construct from the 
parent plasmid R46 [24], and confers ampicillin resistance via β-lactamase production. 
Moderate inhibitory activity against the transfer of TP114 and PKM101 was demonstrated by 
RC despite a weak antibacterial and resistance modifying effect, signifying a different 
mechanism (Figure 1). RC is notable for its phenolic constituents and this class of compound 
are typified by bharangin isolated from Pygmacopremna herbacea (Roxb), together with 
gossypetin and gossypin, known to cause the loss of the TP181 plasmid  as well as a 
penicillinase-conferring plasmid in E. coli 46R41 [25]. Novobiocin was used as the reference 
control at 10 mg/L, having 110% and 83% plasmid conjugal transfer frequency for PKM 101 
and TP114, respectively. Synergy in whole plant medicines or crude extract treatments is 
very commonly responsible in bioactive extracts, especially given that many folklore 
medicines are co-administered with one or more preparations [10]. In RC, the combinatorial 
effect of the crude extract may possibly facilitate transport across the bacterial cell wall, 
which could aid maximum absorption of the drug to assist inhibition of the conjugation 
process.  However, the exact mechanism of action of the crude extract is not known but 
further bioassay-guided isolation of the active extract is currently being examined. 
 
2.5 SRB cytotoxicity potential of the extracts 
 
Numerous assays such as  MTT (3- (4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide),  XTT (2,3–bis(2-methoxy-4-nitro-5-sulphophenyl)-2H-tetrazolium-5-carboxanilide 
sodium salt) and SRB (sulphorhodamine B) have been employed to evaluate toxic effects of 
chemicals on the membrane integrity, mitochondrial function or protein synthesis in 
mammalian cells [26]. The sulphorhodamine B assay is considered the preferable approach 
based on the ability to bind to protein basic amino acid residues of trichloroacetic acid (TCA) 
fixed cells [27]. It is sensitive, simple, reproducible and more rapid than the formazan-based 
assays with better linearity without a time sensitive measurement as regarding the MTT or 
XTT assays [28, 29]. The effect of the RC (IC50>500mg/L) extract on HepG2 cell viability 
was assessed using a colorimetric assay that evaluates cell number indirectly by staining total 
cellular protein with the SRB dye [28] as presented in Figure 2. The RC extracts did not 
impair lysosomes as compared with the standard doxorubicin (0.5mg/L: 52.45%) a 
chemotherapeutic agent used for the treatment of many different cancer types. A similar 
observation was reported by Davis et al. [30] and thus supports the safe use of this botanical 
as complementary and alternative therapy in the prevention or treatment of certain health 
problems. The weak toxic effect could be linked to its hydrophilic nature inhibiting the 
interaction with the cell membranes where signal transduction pathways occur [31]. 
3. Materials and Methods 
3.1 Plant extracts preparation 
Rosa canina L (RC) fruits were obtained in fully dried and powdered form from Herbs in a 
Bottle Ltd UK. Fifty grams (50g) of the dried powdered materials were extracted in 300 mL 
of methanol, at room temperature by constant mechanized agitation in an ultrasonic bath, for 
45 min. The extract was filtered using a Buchner funnel and Whatman No.1 filter paper. The 
volume was concentrated under vacuum at 40°C to recover the methanol, air-dried, weighed 
and stored in a refrigerator at 6oC for future use.  
3.2 Bacterial strains 
The antibacterial assay was performed against strains of Staphylococcus aureus: SA1199B 
and XU212 are MDR strains that overexpress the NorA and TetK efflux transporter proteins 
with a high level of resistance to norfloxacin and tetracycline, respectively. EMRSA-15 and 
EMRSA-16 are the major epidemic methicillin-resistant S. aureus strains in UK hospitals [3, 
4]. S. aureus ATCC25923, E. coli NCTC 10418 and P. aeruginosa NCTC 10662 are standard 
susceptibility testing control strains. S. aureus RN-4220 is a macrolide-resistant strain, while 
K. pneumoniae 342 and P. vulgaris 10330 are MDR clinical isolates. The plasmid conjugal 
inhibitory potential of RC extract was tested on a conjugal transfer system of E. coli bearing 
the TP114 plasmid, which encodes for kanamycin resistance and E. coli harbouring the PKM 
101, which codes for ampicillin resistance. The recipient did not harbour plasmids but had 
chromosomally encoded resistance to streptomycin. All the bacteria and plasmids tested were 
obtained from Dr. Paul Stapleton UCL School of Pharmacy. 
3.3 Cell culture and maintenance 
The HepG2 cell lines (American Type Culture Collection) were obtained from Prof. Andreas 
Kortenkamp formerly at the UCL School of Pharmacy. HepG2 cells were replenished with 
new growth medium every 2-3 days and sub-cultured every 3-4 days when they were 80% 
confluent. Cells were maintained in DMEM (Invitrogen, UK) containing 10% foetal bovine 
serum (GIBCO 10010) and antibiotics [penicillin (100 IU/mL) and streptomycin (100 
mg/L)], incubated at 37oC in a 5% CO2 humidified atmosphere and split when confluent. The 
cell density was adjusted to7.5 x 104 cells/mL before exposure to different concentrations of 
plant extracts prepared in 1% w/v DMSO. 
3.4 Total phenolic content (TPC) 
The total phenolic content of the methanol extract from RC was determined with Folin 
Ciocalteu reagent using the method of Lister and Wilson [32] with slight modification. A 
volume of 0.5 mL of the plant extract (1000 mg/L) was added to 2.5 mL of 10% v/v Folin-
Ciocalteu reagent (FCR) and 2 mL of 20,000 mg/L Na2CO3. The resulting mixture was 
incubated at 45oC with shaking for 15 min, followed by measuring the absorbance at 765 nm. 
The calibration curve of the standard tannic acid (1 mL; 25-400 mg/L) was prepared 
following the same method. The experiment was conducted in triplicate, and the results were 
reported as mean ± SD values. Tannic acid equivalents (TAE) in the plant extract was 
calculated by the following formula: T = C.V/M. Where T was the TPC (mg/g) of the extract 
in TAE; C was the concentration of tannic acid established from the calibration curve, V was 
the volume of the extract (mL) and where M was the weight of the extract (g). 
3.5 Minimum Inhibitory Concentration (MIC) assay 
The minimum inhibitory concentrations (MICs) of the antibiotics and plant extract were 
determined against resistant bacteria using the method described by Shiu and Gibbons [33]. 
The bacterial strains and isolates were grown at 37°C overnight on nutrient agar and inocula 
of the test organisms were prepared in normal saline (9 g/L) and compared with a 0.5 
McFarland standard and diluted to achieve 5 × 105 CFU/mL. A volume of 100 µL of Mueller 
Hinton broth (MHB) was dispensed into 96 wells of microtitre plate. A stock solution of 
antibiotics or drug extracts was prepared in dimethyl sulfoxide (DMSO) (Sigma) and further 
diluted in MHB (1.5 mL) to reduce DMSO concentration to 1% or below. The stock solution 
(100 μL) was serially diluted into each well, mixed with 100 μL of standardized bacterial 
inoculum to give a final concentration that ranged between 512 and 1 mg/L for the extract 
and 128 to 0.03 mg/L for the antibiotics. All procedures were performed in duplicate; the 
plates were incubated at 37°C for 18 h. A volume of 20 μL of a 5 g/L methanol solution of 3-
[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT; Sigma) was added to 
each well and incubated for 30 min. A blue coloration indicated bacterial growth while the 
MIC was recorded as the lowest concentration at which no visible growth was observed. 
3.6 Bacterial resistance modulation assay 
For evaluation of extracts as antibiotic resistance modulators, MICs of norfloxacin and 
tetracycline were determined in the presence or absence of sub-inhibitory concentrations 
(SIC) of the extract (64 - 512 mg/L) against susceptibility testing control strain S. aureus 
ATCC 25693 and three resistant S. aureus isolates: XU 212, SA1199B and EMRSA-16 
following the procedure described by Oluwatuyi et al. [34] with slight modification. A 
volume of 100 µL of MHB was dispensed in each well except wells in column 1 that 
contained 100 µL of the extract. The samples at the stock concentrations (256 - 2048 mg/L) 
were introduced into wells 2-10 while 100µL of the appropriate antibiotic (MICs) was added 
into well 1 and serially diluted (512 to 1 mg/L) across the plate leaving well 11 empty for 
final growth control and well 12 as sterility controls. To the wells in rows four to six were 
added 100 µL of 20 mg/L reserpine (a modulatory agent). All strains were cultured on 
nutrient agar slope before MIC determination. Overnight cultures of each strain were 
prepared in 9 g/L saline to an inoculums density of 5 × 105 CFU/mL. To the wells were 
added 100 µL of a standardised inoculum, but wells in rows seven and eight were maintained 
free from the extracts and reserpine. All experiments were performed in triplicate under 
aseptic conditions. The MIC was determined as mentioned above. 
3.7 Plasmid conjugation inhibition assay 
The plasmid conjugal transfer inhibition assay was performed by the broth mating method 
described by Rice and Bonomo [35] with some modifications. Mating between the plasmid-
containing donors strains E. coli K12 J53 and the recipients E. coli ER1793 and JM 109 were 
performed in Luria-Bertani (LB) broth.  The independent overnight cultures of the plasmids 
were inoculated into 5 mL of fresh LB broth and incubated overnight with shaking at 37oC.  
Donor and recipient cultures were mixed 1:1 in 100 μL of LB with 100 mg/L of each of the 
extracts or 10 mg/L of standard novobiocin to a final volume of 200 μL and incubated 
overnight at 37oC.  For time course experiments, overnight cultures were mixed and mated in 
the presence of the drug and incubated for the time periods stated. Only the bacteria that had 
successfully taken up the resistance gene and become resistant will grow indicating plasmid 
conjugation. 
3.8 Sulphorhodamine B (SRB) assay 
The method described by Houghton et al. [29] was adopted to test for the toxicity of the plant 
extract using the HepG2 cell line. A volume of 100 μL cell suspension of optimum density 
was introduced into each well of a 96-well plate. Plant extract concentrations ranged between 
15.625 and 500 μg/mL and were prepared in the culture medium and 100μL of each extract 
concentration was added to the cell monolayer and control well. Monolayer cells were 
incubated with the drug extracts or standard doxorubicin (positive control) for 48 h, and cells 
were fixed with ice-cold TCA for 1 h at 4oC. After incubation, the plates were washed five 
times in sterilized distilled water and then air dried. A volume of 50 μL of sulphorhodamine 
B (0.4%w/v in 1%v/v acetic acid) solution was added to each well of the dry 96-well plates 
and allowed to stain at room temperature for 30 min. The SRB unbound dye solution was 
removed after staining by washing the plates five times with 1% v/v acetic acid. The bound 
SRB dye was solubilised by adding 100 μL of 10 mM non-buffered Tris Base (pH 10.5) to 
each well, shaking for 5 min. The plates were read in a 96-well plate reader at 492 nm. The 
mean background absorbance was subtracted and the mean values of each drug concentration 
were calculated. The IC50 values of tested extract was the calculated. 
3.9 Statistics 
Data analysis was done with Microsoft Excel to obtain descriptive statistics. Means were 
separated by the Duncan multiple test using SAS. The different levels of significance within 
the separated groups were analyzed using one way analysis of variance (ANOVA). Values 
were considered significant at P<0.05. 
4. Conclusion 
We have shown that while the RC extract had mild to poor antibacterial activity, the sample  
was able to potentiate tetracycline activity against tetracycline-resistant strain XU212 
possessing a multidrug efflux mechanism and had a moderate inhibitory effect on plasmid 
conjugation. Encouragingly, the RC extract did not exhibit any significant toxic effect to 
mammalian cells suggesting the inhibitory was specific in nature.  
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Figure 1:  Percentage (%) plasmid transfer frequency of PKM 101 and TP114 in the presence 
and absence of Rosa canina extracts (100 mg/L). **P<0.05 compared to novobiocin (10 
mg/L) treatment. 
 
 
 
 
 
 
 Figure 2: Sulphorhodamine B viability assay of HepG2 cells treated with methanol extracts 
from Rosa canina (RC) fruits. Confluent cultures were treated for 48 h prior to SRB assay. 
Data are expressed as % of control ± SD (n=6). Doxorubicin (0.5mg/L) was used as postive 
control. 
 
 
 
 
 
 
 
 
 Table 1: Antibacterial activities of methanol crude extracts from Rosa canina fruits against 
MRSA and MDR bacterial strains 
Norx stands for Norfloxacin; Tet: Tetracycline; Ciprox; Ciprofloxacin and Ery; 
Erythromycin. RC; Rosa canina.¶ denotes bacteria with efflux protein transporter, SA-1199B 
possesses the NorA efflux transport protein, RN4220 (MsrA) XU212 (TetK), EMRSA-15 
and -16 (mecA) and ⃰ ATCC25923 a standard laboratory strain. 
 
 
 
 
 
 
 
                 MIC of plant extracts/ antimicrobial agents (mg/L) 
Bacteria RC Ciprox  Tet Norx Ery 
Proteus vulgaris (10330) 512 32    
Klebsiella pneumonia (342) >512 ≤0.03    
Pseudomonas aeruginosa (10662) 256 ≤0.03    
Escherichia coli (NCTC 10418) >512 ≤0.06    
EMRSA-15 256  0.25   
EMRSA-16 512  0.25   
¶XU212 >512  16   
¶SA1199B >512   32  
*ATCC25923 >512   0.5  
¶RN4220 >512    32 
 Table 2: Minimal inhibitory concentrations (mg/L) of selected antimicrobial agents in the 
presence and absence of plant extracts (MIC/4) and reserpine (20mg/L)  
Treatment EMRSA-16 
(mecA) 
SA1199B 
(norA) 
ATCC25923 
 
 XU212 
(TetK) 
Norfloxacin 128 32 0.5 - 
Tetracycline - - - 128 
RC + Norfloxacin 128(0)§ 64 0.5(0)§ - 
Reserpine + Norfloxacin 128(4)§ 4(8)§ 0.125(4)§ - 
RC + Tetracycline - - - 2(64)§ 
Reserpine + Tetracycline - - - 32(4)§ 
RC, Rosa canina; Norfloxacin; Tetracycline and Norfloxacin were used as positive control. § 
denotes potentiation values 
 
 
